Breast cancer is a cancer that is on the rise among women. It is the most common cancer in women, although men can also get it. It occurs when breast cells grow out of control and form a tumor.
According to the World Health Organization (WHO), breast cancer caused 670,000 deaths worldwide in 2022. 1 in every 5 cancer cases worldwide is due to breast cancer. This number is even higher in India, where 30% of the total cancer cases in women are of breast cancer.
Big hope for women suffering with Cancer
There are many medical treatments and medicines available for breast cancer, including surgery, chemotherapy, radiotherapy, hormone therapy, immunotherapy and targeted therapy etc. Doctors and scientists around the world are working on creating new treatments and medicines for breast cancer. In this series, India's pharmaceutical company Shashvi Remedies has developed a new formulation, which can destroy 80% of breast cancer cells in 72 hours. This can become a big hope for women suffering from breast cancer and can bring revolutionary changes in cancer treatment.
Formulation prepared after 10 years of research
The formulation prepared by Mumbai-based Shashvi Remedies for the treatment of breast cancer has been developed after 10 years of research, development and testing to make it perfect. Shashvi Remedies founder Sonal Bansal, AK Bansal and co-founder Birendra Singh Negi, Dr Kiran, Digant Sharma and their team have worked very hard to make it. This success is set to bring a new era in the treatment of breast cancer.
Breast cancer is spreading rapidly all over the world including India
Breast cancer has been identified as the most common malignant disease worldwide. According to research data released by WHO and oncology research agencies, one in every five cancer cases is related to breast cancer. In the year 2020, it was the leading cause of cancer cases in women. More than 25% of the total cancer cases in women worldwide and more than 30% in India are breast cancer cases. The report also states that the global rate of cancer cases is estimated to increase by 11.6% annually.
The formulation was successful in all the necessary testing
This formulation of Shashvi Remedies is clinically tested and has been successful in all the necessary testing, such as - In-vitro test: In-vitro tests conducted on human breast cancer cell line (MCF7) in 2018 and 2024 found that this formulation eliminated more than 80% of cancer cells within 72 hours. Along with this, its results were also impressive in terms of safety. In-vivo test: In an in-vivo test study conducted at a renowned government institute in Mumbai, it was found that this formulation is 100% safe on healthy cells. It has been considered an extraordinary advancement in cancer treatment.
The formulation is safe and effective
Sonal Bansal, director and spokesperson of Shashvi Remedies, said, 'This formulation is safe and has the potential to save countless lives. Research and testing have been done for about ten years to make it. This achievement by Shasvi Remedies is a significant step forward for the entire pharmaceutical industry. It is a huge breakthrough for cancer patients and a ray of hope for their families. Our formulation specifically targets breast cancer cells without harming healthy tissue. Also, we aim to create a universal breast cancer vaccine that will take us closer to a future where cancer is not only treatable but also preventable.
Disclaimer: This article is for general information only. It cannot in any way be a substitute for any medicine or treatment. Always consult your doctor for more information.